Ansell Limited Net Assets

Latest as of June 2025: €1.98 Billion EUR ≈ $2.32 Billion USD

Ansell Limited net assets. Based on the latest financial reports, Ansell Limited (PD1A) has net assets worth €1.98 Billion EUR (≈ $2.32 Billion USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€3.32 Billion ≈ $3.88 Billion USD) and total liabilities (€1.34 Billion ≈ $1.57 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See how leveraged is Ansell Limited's balance sheet to measure how much of total assets are equity-financed.

Key Net Assets Metrics

Metric	Value
Current Net Assets	€1.98 Billion
% of Total Assets	59.68%
Annual Growth Rate	5.8%
5-Year Change	26.72%
10-Year Change	29.53%
Growth Volatility	27.89

Net Assets of Ansell Limited (2004–2025)

Net assets of Ansell Limited from 2004 to 2025. This chart illustrates how Ansell Limited's net assets have evolved over time, based on quarterly financial data. Also explore PD1A year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Annual Net Assets for Ansell Limited (2004–2025)

The table below shows the annual net assets of Ansell Limited from 2004 to 2025. For live market cap and overall valuation, see PD1A market cap overview.

Year	Net Assets	Change
2025-06-30	€1.98 Billion ≈ $2.32 Billion	+3.80%
2024-06-30	€1.91 Billion ≈ $2.23 Billion	+18.25%
2023-06-30	€1.62 Billion ≈ $1.89 Billion	+3.78%
2022-06-30	€1.56 Billion ≈ $1.82 Billion	-0.51%
2021-06-30	€1.56 Billion ≈ $1.83 Billion	-23.49%
2020-06-30	€2.04 Billion ≈ $2.39 Billion	+1.68%
2019-06-30	€2.01 Billion ≈ $2.35 Billion	-4.11%
2018-06-30	€2.10 Billion ≈ $2.45 Billion	+31.30%
2017-06-30	€1.60 Billion ≈ $1.87 Billion	+4.36%
2016-06-30	€1.53 Billion ≈ $1.79 Billion	+31.21%
2015-06-30	€1.17 Billion ≈ $1.36 Billion	+2.29%
2014-06-30	€1.14 Billion ≈ $1.33 Billion	+90.97%
2006-06-30	€597.22 Million ≈ $698.22 Million	+32.01%
2005-06-30	€452.40 Million ≈ $528.90 Million	-25.50%
2004-06-30	€607.26 Million ≈ $709.95 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Ansell Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 128744668000.0% over the analyzed period, indicating profitable operations and earnings retention.

Ansell Limited Net Assets Breakdown (June 2025)

Ansell Limited net assets breakdown by equity component as of June 2025.

Component	Amount	Percentage
Retained Earnings	€1.10 Billion	55.88%
Other Components	€866.40 Million	44.12%
Total Equity	€1.96 Billion	100.00%

Ansell Limited Competitors by Market Cap

The table below lists competitors of Ansell Limited ranked by their market capitalization.

Company	Market Cap
Cal-Comp Electronics (Thailand) Public Company Limited TW:9105	$2.63 Billion
AstraZeneca PLC LSE:AZN	$2.63 Billion
Clicks JSE:CLS	$2.63 Billion
Shanghai Bairun Flavor & Fragrance Co Ltd SHE:002568	$2.63 Billion
First Bancorp NASDAQ:FBNC	$2.63 Billion
CLARIANT ADR 1/SF 4 F:CLRS	$2.63 Billion
Empresas CMPC SN:CMPC	$2.63 Billion
ZIM Integrated Shipping Services Ltd. F:2SV	$2.63 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Ansell Limited's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 1,894,900,000 to 1,963,600,000, a change of 68,700,000 (3.6%).
Net income of 101,600,000 contributed positively to equity growth.
Dividend payments of 63,700,000 reduced retained earnings.
Share repurchases of 4,400,000 reduced equity.
Other factors increased equity by 35,200,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	€101.60 Million	+5.17%
Dividends Paid	€63.70 Million	-3.24%
Share Repurchases	€4.40 Million	-0.22%
Other Changes	€35.20 Million	+1.79%
Total Change	€-	3.63%

Book Value vs Market Value Analysis

This analysis compares Ansell Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.15x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 1.46x to 1.15x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2017-06-30	€10.69	€15.60	x
2018-06-30	€14.59	€15.60	x
2019-06-30	€15.07	€15.60	x
2020-06-30	€15.78	€15.60	x
2021-06-30	€12.18	€15.60	x
2022-06-30	€12.26	€15.60	x
2023-06-30	€12.70	€15.60	x
2024-06-30	€13.04	€15.60	x
2025-06-30	€13.52	€15.60	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Ansell Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 5.17%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 5.07%
• Asset Turnover: 0.60x
• Equity Multiplier: 1.69x
Recent ROE (5.17%) is below the historical average (12.58%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2004	10.28%	7.99%	0.72x	1.79x	€1.68 Million
2005	21.91%	11.72%	0.93x	2.02x	€53.90 Million
2006	14.46%	10.27%	0.77x	1.83x	€26.65 Million
2014	3.72%	2.63%	0.67x	2.10x	€-70.70 Million
2015	16.28%	11.40%	0.69x	2.06x	€72.32 Million
2016	14.19%	10.12%	0.69x	2.04x	€63.29 Million
2017	12.20%	10.75%	0.56x	2.02x	€34.59 Million
2018	31.56%	32.51%	0.59x	1.64x	€447.63 Million
2019	7.99%	7.45%	0.63x	1.70x	€-40.13 Million
2020	11.40%	9.83%	0.66x	1.76x	€28.49 Million
2021	15.90%	12.17%	0.74x	1.76x	€91.58 Million
2022	10.29%	8.13%	0.78x	1.62x	€4.41 Million
2023	9.26%	8.96%	0.65x	1.58x	€-11.79 Million
2024	4.04%	4.72%	0.50x	1.71x	€-112.99 Million
2025	5.17%	5.07%	0.60x	1.69x	€-94.76 Million

Industry Comparison

This section compares Ansell Limited's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

Industry: Medical Instruments & Supplies
Average net assets among peers: $5,548,175,105
Average return on equity (ROE) among peers: -88.74%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Ansell Limited (PD1A)	€1.98 Billion	10.28%	0.68x	$2.63 Billion
SCHOTT Pharma AG & Co. KGaA (1SXP)	$709.04 Million	17.68%	0.69x	$2.39 Billion
RENAU.UNSP.ARD 1/5 EO-20 (56S0)	$4.02 Billion	4.35%	1.05x	$17.02 Billion
MEDIMI AB AK (79T)	$332.69K	-959.52%	4.12x	$1.70 Million
TEVANO SYSTEMS HLDGS INC. (7RBA)	$-736.70K	0.00%	0.00x	$210.67K
STEVANATO GROUP SPA O.N. (87N)	$1.13 Billion	12.86%	0.83x	$1.05 Billion
Carl Zeiss Meditec AG (AFX)	$1.24 Billion	10.83%	0.31x	$2.23 Billion
CARL ZEISS MEDITEC ADR 1 (AFXA)	$2.06 Billion	8.69%	0.65x	$2.14 Billion
Bio-gate AG (BIG1)	$3.45 Million	-46.99%	0.52x	$7.12 Million
COLOPLAST SP.ADR 1/10 DK1 (CBH)	$8.17 Billion	59.07%	0.94x	$12.73 Billion
ESSILORLUXOTTICA 1/2/O.N. (ESLC)	$38.15 Billion	5.64%	0.59x	$67.43 Billion

About Ansell Limited

F:PD1A Germany Medical Instruments & Supplies

Market Cap

$2.63 Billion

€2.25 Billion EUR

Market Cap Rank

#5094 Global

#845 in Germany

Share Price

€15.60

Change (1 day)

-0.64%

52-Week Range

€15.50 - €21.00

All Time High

€23.56